NO983825L - Dosering av ibuprofen - Google Patents

Dosering av ibuprofen

Info

Publication number
NO983825L
NO983825L NO983825A NO983825A NO983825L NO 983825 L NO983825 L NO 983825L NO 983825 A NO983825 A NO 983825A NO 983825 A NO983825 A NO 983825A NO 983825 L NO983825 L NO 983825L
Authority
NO
Norway
Prior art keywords
dosage form
ibuprofen
dosage
fever
bicarbonate
Prior art date
Application number
NO983825A
Other languages
English (en)
Other versions
NO983825D0 (no
Inventor
Ian Ashley Price
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of NO983825D0 publication Critical patent/NO983825D0/no
Publication of NO983825L publication Critical patent/NO983825L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO983825A 1996-02-21 1998-08-20 Dosering av ibuprofen NO983825L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9603699.1A GB9603699D0 (en) 1996-02-21 1996-02-21 Therapeutic composition
PCT/EP1997/000841 WO1997030699A2 (en) 1996-02-21 1997-02-19 Dosage form of ibuprofen

Publications (2)

Publication Number Publication Date
NO983825D0 NO983825D0 (no) 1998-08-20
NO983825L true NO983825L (no) 1998-10-20

Family

ID=10789176

Family Applications (1)

Application Number Title Priority Date Filing Date
NO983825A NO983825L (no) 1996-02-21 1998-08-20 Dosering av ibuprofen

Country Status (25)

Country Link
US (1) US20020034540A1 (no)
EP (1) EP0881899B1 (no)
JP (2) JP2000507922A (no)
KR (1) KR19990087084A (no)
CN (1) CN1215989A (no)
AT (1) ATE273696T1 (no)
AU (1) AU722991B2 (no)
BG (1) BG64165B1 (no)
CA (1) CA2246344C (no)
CZ (1) CZ298371B6 (no)
DE (1) DE69730314T2 (no)
DK (1) DK0881899T3 (no)
ES (1) ES2227670T3 (no)
GB (1) GB9603699D0 (no)
HU (1) HUP9901454A3 (no)
IL (1) IL125803A0 (no)
NO (1) NO983825L (no)
NZ (1) NZ331416A (no)
PL (1) PL187383B1 (no)
PT (1) PT881899E (no)
RU (1) RU2182000C2 (no)
SK (1) SK285032B6 (no)
UA (1) UA55407C2 (no)
WO (1) WO1997030699A2 (no)
ZA (1) ZA971446B (no)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5955107A (en) * 1997-12-12 1999-09-21 Fmc Corporation Pharmaceutical suspension tablet compositions
IT1301966B1 (it) * 1998-07-30 2000-07-20 Zambon Spa Composizioni farmaceutiche ad attivita' analgesica
US20030026835A1 (en) * 1999-02-15 2003-02-06 Sumitomo Pharmaceuticals Company Limited Tablets disintegrating rapidly in the oral cavity
US6368618B1 (en) 1999-07-01 2002-04-09 The University Of Georgia Research Foundation, Inc. Composition and method for enhanced transdermal absorption of nonsteroidal anti-inflammatory drugs
NZ508292A (en) * 1999-11-24 2002-08-28 Mcneil Ppc Inc Treatment of migraine symptoms with ibuprofen and salts thereof
KR100523242B1 (ko) * 2000-05-18 2005-10-24 한미약품 주식회사 이부프로펜을 함유하는 정제 조성물
WO2002083105A2 (en) * 2001-04-10 2002-10-24 Zagros Pharma Inc. Composition for enhanced absorption of nsaids
CH693586A8 (de) * 2002-10-14 2003-12-15 Roche Consumer Health Ag Darreichungsform von Ibuprofen-Natrium.
US20070218139A1 (en) * 2002-12-20 2007-09-20 Smith Thomas J High Pressure Compaction For Pharmaceutical Formulations
US20040176234A1 (en) * 2003-03-07 2004-09-09 Baker Hughes Incorporated Method for improving separation operation of centrifuges and associated improved separation designs
US20080020042A1 (en) * 2003-10-14 2008-01-24 Peter Gruber Dosage form of sodium ibuprofen
PE20050445A1 (es) * 2003-10-30 2005-06-18 Bayer Consumer Care Ag Forma de presentacion del naproxeno sodico
US20050266031A1 (en) 2004-05-25 2005-12-01 Jay Dickerson Pharmaceutical suspension composition
JP2008500288A (ja) * 2004-05-28 2008-01-10 イメイジノット ピーティーワイ エルティーディー 経口治療用化合物の供給系
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
ES2450648T3 (es) * 2004-06-29 2014-03-25 Takeda Pharma A/S Fabricación de composiciones farmacéuticas con liberación rápida de fármacos insolubles en agua y composiciones farmacéuticas obtenidas mediante el procedimiento de la invención
RU2389480C2 (ru) * 2004-08-12 2010-05-20 РЕКИТТ БЕНКАЙЗЕР ХЕЛТКЭА (Ю Кей) ЛИМИТЕД Гранулы, содержащие нпвлс и сахарный спирт, изготовленные экструзией из расплава
ZA200702694B (en) * 2004-09-30 2008-07-30 Scolr Pharma Inc Modified release ibuprofen dosage form
US20060068009A1 (en) * 2004-09-30 2006-03-30 Scolr Pharma, Inc. Modified release ibuprofen dosage form
US20070077297A1 (en) * 2004-09-30 2007-04-05 Scolr Pharma, Inc. Modified release ibuprofen dosage form
WO2006056042A1 (en) * 2004-11-03 2006-06-01 Equitech Corporation Nsaid compositions exhibiting clinical superiority
US20060177501A1 (en) * 2005-02-09 2006-08-10 Boehringer Ingelheim International Gmbh Film Coated Tablets Containing Ibuprofen
EP1800667A1 (en) 2005-12-23 2007-06-27 Losan Pharma GmbH Rapidly solubilizing ibuprofen granulate
ES2546258T3 (es) 2005-03-22 2015-09-22 Stada Arzneimittel Ag Ibuprofeno solubilizado
WO2007035448A2 (en) * 2005-09-19 2007-03-29 Albemarle Corporation Highly concentrated pourable aqueous solutions of potassium ibuprofen their preparation and their uses
US7811604B1 (en) 2005-11-14 2010-10-12 Barr Laboratories, Inc. Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
AU2006317530B2 (en) 2005-11-28 2011-09-01 Imaginot Pty Ltd Oral therapeutic compound delivery system
KR101288924B1 (ko) * 2006-08-16 2013-07-24 에스에스 세야쿠 가부시키 가이샤 경구투여용 제제
FI20080348A0 (fi) * 2008-02-15 2008-05-09 Atacama Labs Oy Uudenlainen farmaseuttinen formulaatio
FI20070521L (fi) * 2006-11-10 2008-05-11 Atacama Labs Oy Rakeita, tabletteja ja rakeistusmenetelmä
US8951562B2 (en) * 2006-11-10 2015-02-10 Atacama Labs Oy Method and apparatus or dry granulation
US7749537B2 (en) * 2006-12-04 2010-07-06 Scolr Pharma, Inc. Method of forming a tablet
BRPI0719486A2 (pt) * 2006-12-20 2014-02-18 Duramed Pharmaceuticals Inc "forma farmacêutica sólida oral desitegrante, não-efervescente, métodos para tratar uma mulher que necessite de um contraceptivo de emergência, pacote terapêutico para tratar uma mulher que necessite de contracepção de emergência e processo para a preparação de uma forma sólida de dosagem farmacêutica oral desintegrante, não-efervescente"
CA2723409C (en) * 2008-05-09 2016-11-08 Atacama Labs Oy Method and apparatus for dry granulation
WO2010011522A1 (en) 2008-07-21 2010-01-28 Albemarle Corporation High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
US9629809B2 (en) * 2008-07-21 2017-04-25 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
WO2011001228A1 (en) * 2008-08-14 2011-01-06 Shasun Chemicals And Drugs Limited Aryl alkyl carboxylic acid salts, process for preparation and dosage forms
RU2715680C2 (ru) * 2009-06-22 2020-03-03 ВАЙЕТ ЭлЭлСи Таблетки ибупрофена натрия и способы изготовления фармацевтических композиций, включающих ибупрофен натрия
AU2015264861C1 (en) * 2009-06-22 2017-11-16 Pf Consumer Healthcare 1 Llc Sodium ibuprofen tablets and methods of manufacturing pharmaceutical compositions including sodium ibuprofen
AU2014200704C1 (en) * 2009-06-22 2018-12-06 Pf Consumer Healthcare 1 Llc Sodium ibuprofen tablets and methods of manufacturing pharmaceutical compositions including sodium ibuprofen
JP5974469B2 (ja) * 2010-12-24 2016-08-23 ライオン株式会社 錠剤の製造方法
CN103102259B (zh) * 2011-12-23 2014-02-26 海南正瑞医药科技开发有限公司 一种布洛芬水合物晶体、及含该水合物晶体的药物组合物及其制备方法
WO2015016256A1 (ja) * 2013-07-30 2015-02-05 ライオン株式会社 錠剤
EP2845850A1 (en) 2013-09-10 2015-03-11 ObsEva S.A. Pyrrolidine derivatives as oxytocin/vasopressin V1a receptors antagonists
EP2886107A1 (en) 2013-12-17 2015-06-24 ObsEva S.A. Oral formulations of pyrrolydine derivatives
EP3753921A1 (en) 2014-07-02 2020-12-23 ObsEva S.A. Crystalline (3z,5s)-5-(hydroxymethyl)-1-[(2'-methyl-1,1'-biphenyl-4-yl)carbonyl]pyrrolidin-3-one o-methyloxime useful in methods of treating conditions related to the ot-r activity
EP2965746B1 (en) 2014-07-10 2019-03-13 Santa Farma Ilaç Sanayi A.S. An oral pharmaceutical composition comprising ibuprofen, ibuprofen sodium dihydrate, pseudoephedrine hydrochloride and chlorpheniramine maleate
WO2017060920A1 (en) * 2015-10-05 2017-04-13 Strides Shasun Limited Pharmaceutical compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4837031A (en) * 1987-09-17 1989-06-06 Mallinckrodt, Inc. Compositions containing ibuprofen
DE3922441A1 (de) * 1989-07-07 1991-01-17 Pharmatrans Sanaq Ag Ibuprofen- und s-(+)-ibuprofen-zubereitungen und verfahren zu ihrer herstellung
GEP20002013B (en) * 1991-05-13 2000-04-10 Boots Co Plc Therapeutical Means
DE4216756C2 (de) * 1992-05-21 1994-08-25 Pharmatrans Sanaq Ag 2-Arylpropionsäure-Zubereitungen und Verfahren zu ihrer Herstellung
EP0607467B1 (de) * 1992-12-01 1999-06-02 Spirig Ag Pharmazeutische Präparate S(+)-Ibuprofen enthaltende Arzneimittel

Also Published As

Publication number Publication date
DK0881899T3 (da) 2004-12-20
CA2246344A1 (en) 1997-08-28
CZ261798A3 (cs) 1998-11-11
HUP9901454A3 (en) 2001-04-28
US20020034540A1 (en) 2002-03-21
PL187383B1 (pl) 2004-06-30
ES2227670T3 (es) 2005-04-01
ZA971446B (en) 1997-11-25
CA2246344C (en) 2009-01-20
AU722991B2 (en) 2000-08-17
CZ298371B6 (cs) 2007-09-12
CN1215989A (zh) 1999-05-05
ATE273696T1 (de) 2004-09-15
PL328465A1 (en) 1999-02-01
RU2182000C2 (ru) 2002-05-10
GB9603699D0 (en) 1996-04-17
IL125803A0 (en) 1999-04-11
BG64165B1 (bg) 2004-03-31
UA55407C2 (uk) 2003-04-15
SK114298A3 (en) 1999-01-11
NZ331416A (en) 2000-02-28
JP2009073847A (ja) 2009-04-09
SK285032B6 (sk) 2006-05-04
DE69730314T2 (de) 2005-08-18
BG102744A (en) 1999-05-31
EP0881899B1 (en) 2004-08-18
WO1997030699A3 (en) 1997-10-09
PT881899E (pt) 2004-12-31
WO1997030699A2 (en) 1997-08-28
JP2000507922A (ja) 2000-06-27
DE69730314D1 (de) 2004-09-23
EP0881899A2 (en) 1998-12-09
KR19990087084A (ko) 1999-12-15
NO983825D0 (no) 1998-08-20
AU1793797A (en) 1997-09-10
HUP9901454A2 (hu) 1999-08-30

Similar Documents

Publication Publication Date Title
NO983825D0 (no) Dosering av ibuprofen
ZA899372B (en) Hemostatic collagen paste composition
ES2046083A1 (es) Procedimiento para preparar composiciones de liberacion prolongada.
HK1085495A1 (en) Spherical powder components and solid cosmetic compositions comprising thereof
IL116385A (en) Sulphonamides their manufacture and pharmaceutical compositions containing them
DE69419527D1 (de) Laxiermittel das ballastfasern und dioctyl-sulfosuccinat enthält
NZ333724A (en) Enhancing lean tissue mass and bone mineral content by the administration of calcium compositions
MX9800847A (es) Composiciones cosmeticas en polvo que tienen cobertura mejorada de la piel.
ZA948669B (en) New pyrazine carboxamide derivatives the preparation thereof and their use in pharmaceutical compositions
MY109990A (en) Microfluidised particles of atovaquone and pharmaceutical preparation thereof
AU7738281A (en) Quick disintigrating tablets with delayed release release pharmacological action
NZ510583A (en) Pharmaceutical composition comprising entacapone or nitecapone as well as a cross-linked cellulose derivative
DK1167354T3 (da) Racemisk huperzin A
AU4627096A (en) Pharmaceutical compositions in the form of slow release tablets based on high molecular weight polysaccharide granules
EP0237241A3 (en) Calcium supplement compressed tablets
ZA200405302B (en) Detergent compositions.
HUT75228A (en) Process for preparing a clodronate preparation
ES2178556A1 (es) Cemento de sulfato de calcio con biodegradacion controlada.
RU94026856A (ru) Ноотропное и транквилизирующее средство
JPS5344617A (en) Drug composition
KR880012206A (ko) 구강질환 치료 조성물
ES2032237A1 (es) Procedimiento para preparar carne simulada de marisco.
PL347583A1 (en) A fibrous sound absorbing mass able to be biologically degraded
MX9705281A (es) Formulaciones de acetaminofen de alta carga, compresible directamente.
JPS5655305A (en) Material for repairing dental cavity

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application